Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort.
ALS
CHGB
P413L
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
received:
22
08
2024
revised:
07
09
2024
accepted:
09
09
2024
medline:
29
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
This study investigated the role of the CHGB P413L variant (rs742710) in sporadic amyotrophic lateral sclerosis (sALS) within the Bulgarian population. We analyzed 150 patients with sALS (85 male and 65 female) for the presence of this variant, its potential impact on disease susceptibility, and age of onset. Genotyping was performed using PCR amplification and direct Sanger sequencing. Statistical analyses included comparisons with control data from GnomAD v2.1.1, one-way ANOVA, and Kaplan-Meier survival analysis. Results revealed a higher frequency of the minor T allele in patients with sALS compared to all control groups and a statistically significant increase in carrier genotypes compared to non-Finnish Europeans (χ
Identifiants
pubmed: 39336788
pii: genes15091197
doi: 10.3390/genes15091197
pii:
doi:
Substances chimiques
Chromogranin B
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical University of Sofia
ID : Grant No. D-148/ 03.08.2023
Organisme : European Union-NextGenerationEU
ID : National Recovery and Resilience Plan of the Republic of Bulgaria, project № BG-RRP-2.004-0004-C01